Astek Diagnostics

Astek Diagnostics

Private
MarylandHealthcare & Life Scienceshttps://astekdx.com/

Last Round

VC Round

Jun 17, 2025

Total Funding Raised

$4.45M

Momentum Score

50 /100

Company Overview

Astek Diagnostics is a precision diagnostics company developing a platform to provide rapid antibiotic sensitivity testing. Its flagship product, the Jiddu system, is a single-use cartridge designed to identify the appropriate antibiotic for bacterial infections, particularly Urinary Tract Infections (UTIs), within one hour. This technology aims to reduce the indiscriminate use of antibiotics, combat antimicrobial resistance, and improve patient outcomes by enabling clinicians to prescribe effective treatments swiftly. The company, a spinout from the University of Maryland, Baltimore County (UMBC), was part of the Y Combinator accelerator and is planning a market launch for its product in 2025.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Sensors, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

antibiotic susceptibility testingASTrapid diagnosticsUTI testingantimicrobial resistanceAMR diagnosticsdiagnostic platformpoint-of-care testingPOCTphenotypic ASTinstrument and consumable modelrazor and blade modelFDA Breakthrough Devicesingle-use sensorclinical laboratory testingdiagnostic devicelab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Astek Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Astek Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 17, 2025
Series ASep 27, 2024
GrantSep 15, 2024
SeedApr 2, 2024
SeedJun 22, 2023
Seed
Jun 6, 2023

Key People

Founding team and executive leadership

Mustafa Al-Adhami

Chief Executive Officer

Executive Team

Rick Faint

Chief Financial Officer

Executive Team

Courtney Cavin

Chief Operating Officer

Executive Team

Astek Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 53% MoM.

Astek Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Astek Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Astek Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMaryland
Employee Range13
Year Founded2020
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.